Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation

Keyphrases

• Hepatic Fibrosis 100%
• Hepatic Stellate Cell Activation 100%
• Osthole 100%
• Thioacetamide 31%
• TGF-1 12%
• Liver Injury 12%
• Hepatic Stellate Cells 12%
• Chemokines 6%
• Endothelin-1 (ET-1) 6%
• Fibrosis 6%
• Group Control 6%
• Scar 6%
• Dynamic Process 6%
• Inhibitory Effect 6%
• Liver 6%
• Nuclear Translocation 6%
• Inflammatory Genes 6%
• NF-B 6%
• Therapeutic Effect 6%
• Collagen 6%
• Cirrhosis 6%
• Active Components 6%
• Sprague-Dawley Rats 6%
• Liver Inflammation 6%
• Chemokine Production 6%
• Chronic Hepatic Injury 6%
• Cellular Oxidation 6%
• Hepatic Stellate cells-T6 6%
• Fibrosis-related Genes 6%
• LX-2 6%
• Histological Architecture 6%
• Cnidium Monnieri Fruits 6%
• Cell Contractility 6%
• Rat Liver Fibrosis 6%
• Cnidium Monnieri (L.) Cusson 6%
• Liver Fibrogenesis 6%
• Fibrosis Score 6%
• Progressive Fibrosis 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Liver Fibrosis 100%
• Osthole 100%
• Thioacetamide 31%
• Liver Injury 18%
• Fibrosis 18%
• Chemokine 12%
• Cytokine 6%
• Inflammation 6%
• Tumor Necrosis Factor 6%
• Therapeutic Effect 6%
• Liver Cirrhosis 6%
• Sprague Dawley Rat 6%
• Hepatitis 6%
• Cnidium 6%
• Scar Formation 6%